Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

Everpure, Inc. ⋅ 10-Q ⋅ 6/5 NetApp, Inc. ⋅ 10-K ⋅ 6/5 VEEVA SYSTEMS INC ⋅ 10-Q ⋅ 6/5 Planet Labs PBC ⋅ 10-Q ⋅ 6/5 Rubrik, Inc. ⋅ 10-Q ⋅ 6/5 BEST BUY CO INC ⋅ 10-Q ⋅ 6/5 COOPER COMPANIES, INC. ⋅ 10-Q ⋅ 6/5 DOCUSIGN, INC. ⋅ 10-Q ⋅ 6/5 DILLARD'S, INC. ⋅ 10-Q ⋅ 6/5 ServiceTitan, Inc. ⋅ 10-Q ⋅ 6/5

VERTEX PHARMACEUTICALS INC / MA

Pharmaceutical Preparations | SIC: 2834
Phone: 6173416393

CIK: 0000875320
EIN: 043039129
State Location: MA
State of Inc.: MA

Nasdaq:VRTX

Form: 4

Filing Date: 02 Jun 2026
Report Date: 29 May 2026
Accepted: 02 Jun 2026 02:04 p.m.
Accession Number: 0000875320-26-000228

Act: None
File Number: None
Film Number: None

Documents

Primary Document: FORM 4

Accepted: 02 Jun 2026 02:04 p.m.

0000875320-26-000228-index-headers.html

Last Modified: 02 Jun 2026 02:04 p.m.

0000875320-26-000228-index.html

Last Modified: 02 Jun 2026 02:04 p.m.

0000875320-26-000228.txt

Last Modified: 02 Jun 2026 02:04 p.m.

wk-form4_1780430661.xml

Last Modified: 02 Jun 2026 02:04 p.m.